Tenecteplase Treatment for Acute Ischemic Stroke
Observational RegIstry of Effectiveness and Safety of teNecTeplase in reAl worLd Settings in China
Recruiting
Observational Study
Stroke
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 10,000 (estimated)
- Sponsor
- Beijing Tiantan Hospital · Other
Who this trial is looking for
This trial is looking for adults who have had a stroke and are receiving treatment with tenecteplase in hospitals across China. Participants will be followed for 90 days to evaluate their outcomes and safety of the treatment.
Are You a Good Fit for This Trial?
You may be able to join if
- I am 18 years or older.
- I have been diagnosed with acute ischemic stroke confirmed by imaging.
- I am being treated with intravenous tenecteplase at the hospital.
- I have provided written consent to participate.
- I can complete follow-up assessments.
You may not be able to join if
- I have received reperfusion therapy before being admitted to the hospital.
- I am participating in another clinical trial that may affect this study.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The ORIENTAL study is a prospective, multicenter, continuously enrolled real-world cohort designed to evaluate the effectiveness and safety of intravenous tenecteplase for acute ischemic stroke (AIS) in routine clinical practice across China. Approximately 10,000 patients from about 200 hospitals will be included. Eligible adults with imaging-confirmed AIS who receive tenecteplase as part of stand…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Adults aged 18 years or older;
2. Diagnosed with acute ischemic stroke confirmed by imaging (CT or MRI);
3. Treated with intravenous tenecteplase at the participating institution;
4. Provided written informed consent, signed by the patient or their legally authorized represen…
Contacts